e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CXCR3 ligands and BAL cytology in ILD
D. Vlachakis, J. Muller-Quernheim, G. Zissel (Freiburg, Germany)
Source:
Annual Congress 2005 - From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Session:
From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Session type:
Thematic Poster Session
Number:
722
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Vlachakis, J. Muller-Quernheim, G. Zissel (Freiburg, Germany). CXCR3 ligands and BAL cytology in ILD. Eur Respir J 2005; 26: Suppl. 49, 722
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The expression of the chemokine receptors CXCCR3 and CCR4 on T cells reflects the Th2 switch in the bronchoalveolar lavage (BAL) of idiopathic pulmonary fibrosis (IPF) patients
Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Year: 2004
The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage (BAL) in lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 77s
Year: 2004
CCR5 expression and CC-chemokine levels in broncho-alveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002
The combination of CXCR3 CCR4 peripheral blood and BAL adds discriminative power in the diagnostic work-up for IPF
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Expression of markers of activation and chemokine receptors by bronchoalveolar lavage T-cells from subjects with asthma, eosinophilic bronchitis and normal controls
Source: Eur Respir J 2001; 18: Suppl. 33, 530s
Year: 2001
Clinical implications of CCR5 expression and IL-2 secretion in bronchoalveolar lavage fluid in sarcoidosis
Source: Annual Congress 2008 - Asthma: mechanisms and treatment
Year: 2008
Upregulation of neurokinin-1 receptor expression in bronchoalveolar lavage cells and bronchial epithelium of patients with sarcoidosis compared with normal patients
Source: Eur Respir J 2002; 20: Suppl. 38, 226s
Year: 2002
CC chemokine ligand 1 is released into the airways of atopic asthmatics
Source: Eur Respir J 2006; 28: 59-67
Year: 2006
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 25: 701-707
Year: 2005
CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer.
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Toll-like receptor 4 is overexpressed in bronchoalveolar lavage fluid of patients with fibrotic idiopathic interstitial pneumonias (F-IIPs): preliminary results
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Interleukin-1β and interleukin -1 receptor antagonist in serum and bronchoalveolar lavage of patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 746s
Year: 2006
Chemokines and chemokine receptors mRNA expression in lavage of COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Activation of discoidin domain receptor 1 on CD14 positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006
Clinical implications of CCR5 expression and IL-2 secretion in bronchoalveolar lavage in hypersensitivity pneumonitis
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Surface activation molecules and intracellular cytokines in bronchoalveolar lavage (BAL) and blood CD3+ cells in advanced sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 350s
Year: 2002
Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP.
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients
Source: Eur Respir J 2002; 19: 472-478
Year: 2002
Th1/Th2 and Tc1/Tc2 profiles in bronchoalveolar lavage and sputum induction in pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 107s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept